Title
Spectrum of mutations in the RPGR gene that are identified in 20% of families with X-linked retinitis pigmentosa
Date Issued
01 December 1997
Access level
open access
Resource Type
journal article
Author(s)
Buraczynska M.
Wu W.
Buraczynska K.
Phelps E.
Andréasson S.
Bennett J.
Birch D.G.
Fishman G.A.
Hoffman D.R.
Inana G.
Jacobson S.G.
Musarella M.A.
Sieving P.A.
Swaroop A.
University of Michigan
Publisher(s)
Cell Press
Abstract
The RPGR (retinitis pigmentosa GTPase regulator) gene for RP3, the most frequent genetic subtype of X-linked retinitis pigmentosa (XLRP), has been shown to be mutated in 10%-15% of European XLRP patients. We have examined the RPGR gene for mutations in a cohort of 80 affected males from apparently unrelated XLRP families, by direct sequencing of the PCR-amplified products from the genomic DNA. Fifteen different putative disease-causing mutations were identified in 17 of the 80 families; these include four nonsense mutations, one missense mutation, six microdeletions, and four intronic- sequence substitutions resulting in splice defects. Most of the mutations were detected in the conserved N-terminal region of the RPGR protein, containing tandem repeats homologous to those present in the RCC-1 protein (a guanine nucleotide-exchange factor for Ran-GTPase). Our results indicate that mutations either in as yet uncharacterized sequences of the RPGR gene or in another gene located in its vicinity may be a more frequent cause of XLRP. The reported studies will be beneficial in establishing genotype-phenotype correlations and should lead to further investigations seeking to understand the mechanism of disease pathogenesis.
Start page
1287
End page
1292
Volume
61
Issue
6
Language
English
OCDE Knowledge area
Genética humana
DOI
Scopus EID
2-s2.0-17344363773
PubMed ID
Source
American Journal of Human Genetics
ISSN of the container
00029297
Sponsor(s)
We are grateful to the XLRP patients and their family members who participated in the study. We thank Drs. Kirk Alek, Jacquie Greenberg, John Heckenlively, and Albert Maguire, Ms. Gina Osland, and Ms. Janice Edwards, for some of the families included in mutation analysis. Thanks are also due to Cynthia Chen, Cara Coats, and T. J. Falls, for technical assistance, and to Dorothy Giebel, Jason Cook, and Mitch Gillett, for help in the preparation of the manuscript. This research was supported by the National Institutes of Health grants EY07961 (to A.S.), EY10820 (to J.B.), and EY05627 (to S.G.J.); by grants from The Foundation Fighting Blindness, Hunt Valley, MD (to A.S., D.G.B., G.A.F., M.A.M., P.A.S., and S.G.J.); by a grant from The RP Research Foundation of Canada (to M.A.M.); by a grant from The Chatlos Foundation, Inc. (to S.G.J.); by a grant from The Atkinson Charitable Foundation (to M.A.M.); and by an unrestricted grant from The Research to Prevent Blindness. We also acknowledge NIH grants EY07003 (CORE) and M01-RR00042 (General Clinical Research Center) and a Shared Equipment Grant from the Office of Vice President for Research. A.S. is recipient of a Research to Prevent Blindness Lew R. Wasserman Merit Award.
Sources of information:
Directorio de Producción Científica
Scopus